Accuray
NASDAQ: ARAY
Market snapshot fields show as unavailable when the configured provider does not return a quote for this listing. none · unavailable — no quote returned for this symbol (coverage or listing mismatch).
Robotics Relevance
Significant · Accuray develops CyberKnife robotic radiosurgery systems that deliver precision radiation therapy. Robotic treatment delivery is a central disclosed franchise. EAR classifies Accuray as robotics significant exposure in therapeutic robotics.
Robotics Exposure
Editorial exposure map — not investment advice.
Why Included
CyberKnife robotic radiosurgery platforms — radiation delivery robots are a central disclosed franchise.
EAR Markets is for research and intelligence only and is not financial advice, investment advice, or a recommendation to buy or sell securities.
Market profile · pub-aray